| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease. | Am J Gastroenterol | 2002 | 1.32 |
| 2 | NOD2/CARD15 does not influence response to infliximab in Crohn's disease. | Gastroenterology | 2002 | 1.20 |